When it comes to Trikafta and the other CFTR modulators available today, what do we know about how they affect the health of people with CF? With all the treatments in the CF regimen, how do we determine which treatments are most important and which might be able to take a back seat, especially as modulators become more widespread? What kinds of questions are coming from people with CF, family members, and caretakers based on the things you’re experiencing every day on modulators and conducting treatments? And what kind of research on current therapies is possible based on what we know about established medicines and treatments? In this session we’ll cover issues and questions for people who want to know how modulators impact CF and those who have questions about adjusting treatments or changing their treatment regimen when on modulators.